SYNOPSIS Expression of B and T lymphocyte receptors has been studied in seven cases of reticulum cell sarcoma. In one case, surface receptors and tests of phagocytic function demonstrated the histiocytic origin of the neoplastic cells. In four cases, tumour cells expressed both B and T lymphocyte markers (two cases) or showed a normal pattern of expression of B and T lymphocyte markers. In the other two cases, lymphocyte receptors were not detected, and there was no evidence of phagocytic function: this class of receptor-silent tumours is of uncertain pathogenesis. The significance of these observations is discussed.
In man the different classes of lymphocyte are morphologically indistinguishable by light microscopy, but can be detected by tests which show differences in the reactivity of the cell surface. B lymphocytes carry stainable surface immunoglobulin (Fr6land, Natvig, and Berdal, 1971 ) and express receptors for complement and the Fc portion of the immunoglobulin molecule (Shevach, Jaffe, and Green, 1973) . T lymphocytes lack stainable surface immunoglobulin but show the ability to bind washed sheep red cells (Froland, 1972) under experimental conditions. There is also evidence to show that T lymphocytes carry surface antigens which are not present on B lymphocytes but which they share with brain (Brown and Greaves, 1974) . By exploiting these differences in surface reactivity, or antigenicity, B and T lymphocytes can readily be identified and quantitated in human peripheral blood (Brown and Greaves, 1974; Habeshaw and Young, 1975) .
There have recently been attempts to identify neoplastic cells of B and T derivation in neoplasms of the lymphoid and haematopoietic systems (Smith, Barker, Clein, and Collins, 1973; Shevach et al 1973; Edelson, Kirkpatrick, Shevach, Schein, Smith, Green, and Lutzner, 1974; Jaffe, Shevach, Frank, Berard, and Green, 1974) . In chronic lymphocytic leukaemias most of the examples so far studied have shown the neoplastic cells to be B cell Received for publication 10 December 1974. in type (Pincus, Bianco, and Nussenzweig, 1972; Piessens, Schur, Moloney, and Churchill, 1973; Mellstedt and Petterson, 1974) . These cells express generally a single heavy chain component indicating a clonal origin (Silberman and Schrek, 1974) . In some cases the neoplastic cells lack receptors for complement (EAC) (Shevach et al, 1973) or carry HTLA (human thymic lymphocyte antigen), a T cell marker (Edelson et al, 1974) . In other leukaemias, a prolymphocytic leukaemia (Dewar, Habeshaw, Young, Stuart, Parker, and Wilson, 1974 ) and a variant of chronic lymphocytic leukaemia (Shevach et al, 1973) cells bearing both B and T lymphocyte markers have been described.
In solid tumours of lymph node, lymphocyte receptors of both B and T type have been described. In a lymph node secondary associated with thymic lymphoid tumour the cells were of T lymphocyte derivation (Smith et al, 1973) . In nodular lymphocytic lymphoma, the tumour cells were of B derivation, corresponding to the follicular cells of the normal germinal centre (Jaffe et al, 1974) .
Cellular infiltrates in skin associated with mycosis fungoides, Sezary cell leukaemia, and lymphosarcoma have also been studied (Edelson et al, 1974) . In all cases the infiltrating cells show the characteristics of T lymphocytes.
Macrophages, which may be confused with lymphoid cells, can also be identified in cellular infiltrates, for example, in grafts during rejection and in malignant leukaemic reticuloendotheliosis. This technique makes use of the IgG-sensitized red cells which adhere to macrophages in frozen sections of the appropriate tissue (Shevach et al, 1973) . This technique can be used to identify complement (EAC) or immunoglobulin (EA) receptors in tissue, but it is not suitable for the localization of the sheep receptor (E) expressed by T cells (Shevach et al, 1973; Jaffe et al, 1974) .
There is no firm conviction as to the derivation of the less well differentiated lymphoreticular neoplasms classified as reticulum cell sarcoma. Gall (1958) proposed that within this group of tumours was a group characterized by the resemblance of tumour cells to histiocytes (macrophages), an entity which he termed 'histiocytic malignant lymphoma' (see review by Stuart, 1974) . Lukes (1968) In this study an attempt has been made to identify the neoplastic cell population of reticulum cell sarcoma as being either of T or B lymphoid origin as proposed by Lukes, or as being truly histiocytic, ie, macrophage-like, as proposed by Gall (1958) .
Materials and Methods

CONTROL LYMPH NODES
Control lymph nodes comprise two groups, the first consisting of nine nodes from groin, axillary, cervical, or abdominal groups removed from patients with non-neoplastic conditions. These were classified on the basis of site of origin and light microscopic appearance. The second group consisted of five nodes removed from patients with systemic neoplasia (carcinoma or Hodgkin's disease) which were not microscopically involved by the tumour. These were classified according to site and diagnosis of the primary condition. All nodes were obtained as fresh surgical specimens within minutes of their removal.
NEOPLASTIC LYMPH NODES
These were received as fresh surgical specimens, and were immediately received into Hanks BSS or medium 199 and chilled in ice. The diagnosis of histiocytic lymphoma (reticulum cell sarcoma) was made by frozen section and subsequently confirmed by paraffin section and electron microscopy. The source was inguinal (case 4) cervical (cases 1, 3, 7), and axillary (cases 2, 5). An enlarged spleen, almost totally replaced by tumour, was the source of cells in case 6.
PREPARATION OF LYMPH NODE CELL SUSPENSIONS
The lymph node was sliced into small fragments and immediately transferred to Hepes buffered medium 199, containing 10 units heparin/mI. The fragments were further teased under the medium and cells washed out by gentle pipetting. Cells were filtered through stainless steel gauze, washed twice in medium 199, and the concentration was adjusted to 3 x 106/ml. Samples were smeared and stained with Giemsa, and viability was assessed by trypan blue dye exclusion.
PREPARATION OF SPLEEN CELL SUSPENSION (CASE 6)
Albumin gradients were used to concentrate neoplastic cells from the crude spleen suspension. Discontinuous gradients of bovine serum albumin were set up at 2, 4, 8, 12, 17, 22, 28 , and 35% from stock bovine serum albumin (Armour) diluted with medium 199. Each layer was 4 ml in volume, and the gradients were loaded with 5 ml of cell suspension containing 100 x 106 cells. Sedimentation was allowed to continue for two hours at room temperature under gravity. All cell suspensions were tested for viability and smears were made at each fractionation step to ensure that suspensions were representative. Fraction 6 (22% albumin) contained 60% large abnormal cells, and was used in the receptor studies. The techniques employed here have been described in detail elsewhere (see Habeshaw and Young, 1975 receptor silent population. Cells forming rosettes from the spleen preparation in case 6 can be accounted for by the contaminating lymphocytes and macrophages in the cell population (table III) In two cases (4 and 5) overlap of receptors was noted. Since examining these nodes we have developed techniques which allow simultaneous detection of T and B cell receptors, and an additional case of prolymphocytic leukaemia has been described in which this phenomenon occurred (Dewar et al, 1974) . Other authors have also noted the expression of receptors for IgG (Yoshida and Andersson, 1972) by T lymphocytes undergoing transformation, by cells derived from chronic lymphocytic leukaemia (Shevach et al, 1973) , and by circulating cells in an uncharacterized lymphoproliferative disorder (Sandilands, Gray, Cooney, Browning, Grant, Andersson, Dagg, and Lucie, 1974) . A small population of normal peripheral blood lymphocytes bearing both B and T cell markers has also been described (Dickler, Adkinson, and Terry, 1974 ). There are therefore two possible conclusions to be drawn from cases 4 and 5; either the neoplastic population is derived from a subclass of lymphoid cells bearing both B and T markers, or the population is derived from T lymphocytes which have acquired B cell markers during neoplastic transformation (or vice versa). In both cases the origin of the neoplastic cells is lymphoid rather than histiocytic.
PREPARATION OF RED CELLS AND ROSETTES
In cases 6 and 7, the tumour cells were receptor silent, and therefore not classifiable as either lymphoid or histiocytic in origin. In case 6, and one other receptor silent lymphoma we have studied, progression of the disease was rapid and both patients died within six to nine months of diagnosis. This might suggest that receptor silence is an ominous prognostic sign in lymphoreticular neoplasia. It could be due to loss of receptor characteristics by dedifferentiation of the neoplastic cell, or suggest an origin from a receptor silent class of cell possibly of stromal origin (reticulum cell or reticular macrophage). The presence of small, but detectable amounts of immunoglobulin on the tumour cells in case 7 do not necessarily imply a B cell origin. Weak, diffuse fluorescence of this kind can be observed in carcinoma cells from secondarily involved lymph nodes, and may represent the presence of circulating antitumour-cell antibodies. It is worth mentioning that in our experience carcinoma, or malignant melanoma, cells from involved nodes are also receptor silent. In our two receptor-silent cases the mode of presentation, the histological appearances, and the subsequent clinical behaviour exclude the possibility of metastatic carcinoma or malignant melanoma.
Receptor studies are expensive in time and it is pertinent to ask what contribution they can make to the understanding of lymphoid neoplasms. The contribution of such studies to pathology and medicine has already been assessed (Wybran and Fudenberg, 1974) . In the field of lymphoid neoplasia, the present study has confirmed the views of Lukes and of Gall in proposing lymphoid and histiocytic origins respectively for this group of neoplasms. The overall picture is far from clear; in particular no explanation for the neoplasms with normal ratios of B and T cell markers is satisfied by the current dogma of clonal origin from a single class of neoplastic lymphocyte. Two possibilities are perhaps worthy of further examination: first that the neoplastic state requires the participation of both B and T lymphocytes, as do the normal phenomena of antibody secretion and germinal centre formation. As an alternative, perhaps a fixed neoplastic population sequesters from the circulation a reactive lymphoid population which proliferates in concert in the environment of the node. It is hoped that further investigations of the solid tumours of lymph nodes will cast more light on a difficult subject.
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